4

FORM 4 SUBMISSION

Company: Viridian Therapeutics, Inc.\DE
Filed: October 29, 2020
Period of Report: October 27, 2020
Accession Number: 0000899243-20-029699

View Document ↗ View on SEC.gov ↗